You are here
Family Bank: Cordlife Philippines
Cordlife Medical Philippines is a member of the Cordlife Group Limited family of companies. Cordlife Group Limited owns and operates five cord blood laboratories in Singapore, Hong Kong, India, Indonesia and the Philippines.
Labs and Locations
Unit 101, Building H U.P. AyalaLand, TechnoHub Commonwealth Avenue, Diliman Quezon City, Philippines 1101
Cordlife Group Limited is listed on the Mainboard of the Singapore Exchange (SGX), and together with its subsidiaries, may be called "The Group". Cordlife Group Limited owns five cord blood banks in Singapore, Hong Kong, Indonesia, Philippines and India, and has a direct investment in China Cord Blood Corporation, one of the top banks in China. Cordlife also currently owns a majority stake of Stemlife Malaysia and THAI Stemlife. At present the laboratories in Singapore, Hong Kong, India and the Philippines are accredited by AABB (formerly known as American Association of Blood Banks), meeting the gold standard of private cord blood banking. The Group now comprises of:
Cordlife Group Limited - Singapore
Cordlife (Hong Kong) Limited - Hong Kong & Macau
Cordlife Sciences India Pvt Limited - Kolkata, India
PT Cordlife Persada - Jakarta, Indonesia
Cordlife Medical Philippines, Inc. - Manila, Philippines
Cordlife Group Limited was established in Singapore in 2001 to provide a full suite of cord blood and (subsequently) tissue banking services which include the collection, processing and cryopreservation of cord blood stem cells and umbilical cord tissue. Cordlife has grown rapidly from a fledging start-up company into a multi-national corporation. In 2005, Cordlife established its first overseas cord blood processing and storage facility in Hong Kong. The ISO certified facility, with a storage capacity for 50,000 cord blood and umbilical cord units, is Hong Kong’s largest and most advanced stem cell facility. In 2011, Cordlife introduced the patented technology, CellOptima™, which is exclusively available at Cordlife in Hong Kong, to isolate two types of stem cells from umbilical cord – Epithelial stem cells and Mesenchymal Stem Cells (MSC).
The kit contains a closed system blood bag (brand JMS) that is pre-loaded with the anti-coagulant CPDA-1. The kit also provides the disinfectant Povidone-iodine.
The collection kit is constructed with thermal insulation and validated to maintain room temperature for up to 48 hours during transportation back to the laboratory.
Once we are informed of cord blood collection, our courier service team will pick up the kit for shipping at room temperature to the laboratory for processing and storage.
Parents in the Philippines may have one of two processing options: The first option is to have technicians separate stem cells from the cord blood manually by the traditional method of cell sedimentation and spin. The second option is to have stem cells separated using the fully automated and closed Sepax system from Biosafe. Either way, the final component is the buffy coat layer of the blood, which holds both white cells and stem cells.
Parents are provided with a report describing test results for buffy coat holding white cells and stem cells including total nucleated cells (TNC), post processing sterility, as well as maternal blood infectious disease results.
Final cord blood storage is in 25 ml blood (cryo) bag encased in an overwrap. Blood samples are kept in a quarantine freezer, then moved to long term freezer after they pass testing. Stem cells are stored in the vapour phase of cryogenic nitrogen.
Licensing & Accreditation
- Cordlife Philippines is accredited by AABB
- Cordlife Philippines is certified by ISO 9001:2000
- Registered with the Department of Health (Philippines)
- Cordlife Hong Kong is accredited by the College of American Pathologists (CAP) for their screening laboratory which can detect more than 100 metabolic disorders from urine specimens of newborns. This service is offered in Hong Kong, Indonesia, and the Philippines.
Cordlife Group Limited has released 11 client cords for therapy (6 autologous, 5 allogeneic)
Clients will be covered by a program known as the Cordlife Care360 – a holistic program aimed to safeguard our client and their family.
1) Cordlife assures clients a cord blood unit of suitable match or US$25,000 to defray medical costs if the cord blood loses its viability at point of transplant.
2) Cordlife will cover the cost for additional tests required in the event of a transplant - matching (HLA resolution test) and viability assay.
3) Cordlife has taken additional insurance coverage, to safeguard client and their family from financial loss resulting from direct malpractice.
4) Cordlife provides an alternative facility at no additional cost to clients should the local facility be inaccessible.
Free banking (terms and conditions apply) is given to families when a sibling has a diagnosis for which transplantation is standard therapy.
Special discounts are given to medical doctors and nurses.
One-time upfront fee upon signing of agreement as low as P34,000, and annual fee of P8,000 from child’s 1st birthday. Prices are before VAT. Interest-free installments (up to 12 months) are available for payment of the upfront fee.
Cordlife has an exclusive license on patented technology to store stem cells from the lining of the umbilical cord. This cord lining contains both Epithelial Stem Cells (EpSC) and Mesenchymal Stem Cells (MSC). Parents who are banking cord blood can choose the enhanced services CordPlus (EpSCs + MSCs) or CordBasic plan (MSCs).